Low Serum or Plasma Sodium
Increase in extracellular fluid volume as produced by congestive heart failure, cirrhosis and ascites, producing dilutional hyponatremia
GI loss of sodium from vomiting, diarrhea, or malabsorption, especially with replacement of fluid and not electrolytes
Renal sodium loss from diuretic use or chronic renal insufficiency
Addison's disease producing adrenal insufficiency
Syndrome of inappropriate antidiuretic hormone secretion (SIADH), as caused by a CNS lesion, pulmonary disease, carcinoma, porphyria
Suggested Additional Lab Testing
Tests for the presence of congestive heart failure and cirrhosis
Indicators of renal function, such as creatinine and BUN
Serum aldosterone level
Serum or plasma BUN, and urine sodium and osmolarity, are valuable in demonstrating hyponatremia and differentiating among the causes of hyponatremia.
In SIADH, both urine sodium and urine osmolarity are increased.
In the presence of a diuretic inducing hyponatremia, urine sodium is increased, but urine osmolarity is usually isotonic to plasma.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Next Article in LabMed
Neurology Advisor Articles
- Higher Levels of Cholesterol May Protect Men From Parkinson Disease
- Early Clinical Traits of Multiple Sclerosis Prodrome Identified
- Chronic Pain May Be Contributor to Suicide
- FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
- Low Serum Levels of Thyroid Stimulating Hormone Linked With Prolonged Migraine
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies
- Familial Hemiplegic Migraine Attacks May Be Associated With Cortical Swelling
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine
- Propofol May Decrease Delay in Neurocognitive Recovery